Prophylactic tirofiban versus oral dual antiplatelet therapy in patients undergoing endovascular treatment of intracranial aneurysms: A meta-analysis.

Medicine (Baltimore) · 2026 · PMC13095280 · PMID 41995519

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

Additionally, the combination of prophylactic tirofiban with DAP therapy demonstrated a lower incidence of hemorrhagic events compared with DAP therapy alone and also displayed a positive trend towards reducing the incidence of thromboembolic events.

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.